These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of Patients With and Without Painful Peripheral Neuropathy After Receiving Neurotoxic Chemotherapy: Traditional Quantitative Sensory Testing vs C-Fiber and Aδ-Fiber Selective Diode Laser Stimulation. Nemenov MI; Alaverdyan H; Burk C; Roles K; Frey K; Yan Y; Kazinets G; Haroutounian S J Pain; 2022 May; 23(5):796-809. PubMed ID: 34896646 [TBL] [Abstract][Full Text] [Related]
6. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study. Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced peripheral neuropathy: where are we now? Colvin LA Pain; 2019 May; 160 Suppl 1(Suppl 1):S1-S10. PubMed ID: 31008843 [TBL] [Abstract][Full Text] [Related]
8. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models. Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619 [TBL] [Abstract][Full Text] [Related]
9. Current Diagnosis and Treatment of Painful Small Fiber Neuropathy. Farhad K Curr Neurol Neurosci Rep; 2019 Nov; 19(12):103. PubMed ID: 31773305 [TBL] [Abstract][Full Text] [Related]
10. Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy. Saad M; Psimaras D; Tafani C; Sallansonnet-Froment M; Calvet JH; Vilier A; Tigaud JM; Bompaire F; Lebouteux M; de Greslan T; Ceccaldi B; Poirier JM; Ferrand FR; Le Moulec S; Huillard O; Goldwasser F; Taillia H; Maisonobe T; Ricard D J Neurooncol; 2016 Apr; 127(2):373-80. PubMed ID: 26749101 [TBL] [Abstract][Full Text] [Related]
11. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge. Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. Park SB; Goldstein D; Krishnan AV; Lin CS; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC CA Cancer J Clin; 2013; 63(6):419-37. PubMed ID: 24590861 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735 [TBL] [Abstract][Full Text] [Related]
14. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy. Waseem M; Kaushik P; Tabassum H; Parvez S Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal follow-up of biopsy-proven small fiber neuropathy. MacDonald S; Sharma TL; Li J; Polston D; Li Y Muscle Nerve; 2019 Oct; 60(4):376-381. PubMed ID: 31348533 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Sałat K Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261 [TBL] [Abstract][Full Text] [Related]
18. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB J Cancer Surviv; 2019 Aug; 13(4):495-502. PubMed ID: 31172429 [TBL] [Abstract][Full Text] [Related]
19. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria for idiopathic small fiber neuropathy: A systematic review. Haroutounian S; Todorovic MS; Leinders M; Campagnolo M; Gewandter JS; Dworkin RH; Freeman R Muscle Nerve; 2021 Feb; 63(2):170-177. PubMed ID: 32989823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]